Skip to main content

Radicava Side Effects

Generic name: edaravone

Medically reviewed by Drugs.com. Last updated on Aug 22, 2023.

Note: This document contains side effect information about edaravone. Some dosage forms listed on this page may not apply to the brand name Radicava.

Applies to edaravone: intravenous solution. Other dosage forms:

Serious side effects of Radicava

Along with its needed effects, edaravone (the active ingredient contained in Radicava) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking edaravone:

More common

Less common

Other side effects of Radicava

Some side effects of edaravone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

For Healthcare Professionals

Applies to edaravone: intravenous solution, oral suspension.

General

The most common adverse reactions are contusion, gait disturbance, and headache.[Ref]

Dermatologic

Very common (10% or more): Contusion (up to 15%)

Common (1% to 10%): Dermatitis, eczema, tinea infection, rash, erythema[Ref]

Gastrointestinal

Common (1% to 10%): Nausea[Ref]

Hypersensitivity

Postmarketing reports: Hypersensitivity reactions, anaphylaxis[Ref]

Musculoskeletal

Common (1% to 10%): Ligament sprain[Ref]

Nervous system

Very common (10% or more): Gait disturbance (up to 13%), headache (up to 10%)[Ref]

Other

Common (1% to 10%): Excoriation[Ref]

Renal

Common (1% to 10%): Glycosuria[Ref]

Respiratory

Common (1% to 10%): Respiratory failure/respiratory disorder/hypoxia, upper respiratory tract inflammation, upper respiratory tract infection[Ref]

References

1. Product Information. Radicava (edaravone). Teva Pharma Australia Pty Ltd. 2023.

2. Product Information. Radicava ORS (edaravone). Mitsubishi Tanabe Pharma America (formerly MT Pharma America). 2022;SUPPL-12.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.